Of interest, c-Myc is aberrantly expressed in 60–80% in CRC and universally implicated in promoting colorectal tumorigenesis [38, 39], including colitis-associated colon adenocarcinomas [40–44] and c-Myc expression confers resistance against 5FU [45–48]. Here, MYC is linked to colitis.